Schmidt D M, Sidhu N K, Cianciolo G J, Snyderman R
Howard Hughes Medical Institute, Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7290-4. doi: 10.1073/pnas.84.20.7290.
Retroviral envelope protein p15E and antigenically related proteins have been implicated as potential mediators of immune dysfunction associated with retroviral infections and with neoplasia. Due to its extreme hydrophobicity, purified p15E has not been available in a nondenatured form or in sufficient quantities for detailed studies on the mechanisms of its immunosuppressive effects. Therefore, a plasmid was constructed to direct the synthesis in Escherichia coli of the major hydrophilic region of murine p15E. The purified recombinant p15E derivative, soluble under physiological conditions, inhibited by up to 60% (EC50 = 7.5 nM) the anti-CD3-driven proliferation of human T lymphocytes but had no effect on the proliferation of the transformed T-cell line Jurkat. The recombinant protein also inhibited, by up to an average of 92% (EC50 = 2.1 microM), the proliferation of the murine T-cell line CTLL-2. These data (i) provide direct evidence that a retroviral envelope protein can itself inhibit lymphoproliferative function and (ii) map the inhibitory activity to a specific region of p15E. The availability of soluble, recombinant p15E should facilitate studies of the pathogenesis of the immunosuppression accompanying retroviral infections and neoplastic diseases.
逆转录病毒包膜蛋白p15E及抗原相关蛋白被认为是与逆转录病毒感染和肿瘤形成相关的免疫功能障碍的潜在介质。由于其极强的疏水性,无法获得非变性形式或足够数量的纯化p15E用于对其免疫抑制作用机制进行详细研究。因此,构建了一个质粒以指导在大肠杆菌中合成鼠p15E的主要亲水区。纯化的重组p15E衍生物在生理条件下可溶,能抑制人T淋巴细胞抗CD3驱动的增殖达60%(半数有效浓度EC50 = 7.5 nM),但对转化的T细胞系Jurkat的增殖无影响。该重组蛋白还能抑制鼠T细胞系CTLL-2的增殖,平均抑制率达92%(EC50 = 2.1 microM)。这些数据(i)提供了直接证据,证明逆转录病毒包膜蛋白本身可抑制淋巴细胞增殖功能,(ii)将抑制活性定位到p15E的特定区域。可溶性重组p15E的可得性应有助于研究伴随逆转录病毒感染和肿瘤疾病的免疫抑制发病机制。